Shay Capital LLC Biogen Inc. Call Options Transaction History

Shay Capital LLC

  • $640 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $1.17 Million - $1.61 Million
6,000 New
6,000 $1.6 Million
Q1 2022

May 16, 2022
SELL
$193.77 - $244.14 $1.63 Million - $2.05 Million
-8,400 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$223.92 - $287.77 $1.88 Million - $2.42 Million
8,400 New
8,400 $2.02 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email